Selected as a Doody's Core Title for 2022! A Practical Guide to Contemporary Pharmacy Practice and Compounding is your hands-on, step-by-step guide to receiving and filling prescription drug orders as well as a comprehensive look at the preparation of sterile and non-sterile extemporaneously compounded preparations. This edition is meticulously updated to include the latest practice guidelines and standards, as well as a detailed discussion of the Drug Quality and Security Act (DQSA) of 2013. In addition, it offers a wealth of guidance on processing prescriptions, avoiding dangerous medication and labeling errors, counseling patients and caregivers, and much more - giving you all the knowledge you need to succeed on your exams and safely carry out the practice of pharmacy. Features significant revisions to address the impact of new federal laws/regulations on pharmacy practice. Includes meticulous updates reflecting the latest advances in "formulation science." Includes an expanded list of definitions addressing the interchangeable terminologies that arise due to the emergence of interprofessional education and practice. Offers an expanded discussion on avoiding medication and labeling errors, patient counseling at hospital discharge, sterile dosage form preparation, and much more. Includes updated information about newly approved excipients and manufacturers. Includes a new section on the passage of the DQSA, which amended the Food, Drug, and Cosmetic Act, making a distinction between 503A compounding pharmacies, the traditional prescription-based compounding pharmacies, and 503B outsourcing facilities. Contains all-new photos that clearly illustrate all equipment, materials, and techniques.

Proteins are exposed to various interfacial stresses during drug product development. They are subjected to air-liquid, liquid-solid, and, sometimes, liquid-liquid interfaces throughout the development cycle-from manufacturing of drug substances to storage and drug delivery. Unlike small molecule drugs, proteins are typically unstable at interfaces where, on adsorption, they often denature and form aggregates, resulting in loss of efficacy and potential immunogenicity. This book covers both the fundamental aspects of proteins at interfaces and the quantification of interfacial behaviors of proteins. Importantly, this book introduces the industrial aspects of protein instabilities at interfaces, including the processes that introduce new interfaces, evaluation of interfacial instabilities, and mitigation strategies. The audience that this book targets encompasses scientists in the pharmaceutical and biotech industry, as well as faculty and students from academia in the surface science, pharmaceutical, and medicinal chemistry areas.

This book provides a list of concise extemporaneous ophthalmic preparations, and standardizes the formulation of the products by suggesting specific strength, route of administration, appropriate vehicle, and method of preparation. Pharmaceutical industries have greatly expanded their share of ophthalmic drugs in recent years. However, physicians and pharmacists are frequently called to prepare sterile products intended for ophthalmic use due to lack of availability of licensed drugs in the market. This book contains the most appropriate formulation of each medication based on published and documented stability data. Extemporaneous Ophthalmic Preparations is the first book of its kind, making it a unique and valuable companion for many physicians and pharmacy practitioners who are frequently engaged in the compounding of sterile ophthalmic preparation.

Honey typically has a complex chemical and biochemical composition that invariably includes complex sugars, specific proteins, amino acids, phenols, vitamins, and rare minerals. It is reported to be beneficial in the treatment of various diseases, such as those affecting the respiratory, cardiovascular, gastrointestinal, and nervous systems, as well as diabetes mellitus and certain types of cancers; however, there is limited literature describing the use of honey in modern medicine. This book provides evidence-based information on the pharmaceutical potential of honey along with its therapeutic applications and precise mechanisms of action. It discusses in detail the phytochemistry and pharmacological properties of honey, highlighting the economic and culturally significant medicinal uses of honey and comprehensively reviewing the scientific research on the traditional uses, chemical composition, scientific validation, and general pharmacognostical characteristics. Given its scope, it is a valuable tool for researchers and scientists interested in drug discovery and the chemistry and pharmacology of honey.

Honey typically has a complex chemical and biochemical composition that invariably includes complex sugars, specific proteins, amino acids, phenols, vitamins, and rare minerals. It is reported to be beneficial in the treatment of various diseases, such as those affecting the respiratory, cardiovascular, gastrointestinal, and nervous systems, as well as diabetes mellitus and certain types of cancers; however, there is limited literature describing the use of honey in modern medicine. This book provides evidence-based information on the pharmaceutical potential of honey along with its therapeutic applications and precise mechanisms of action. It discusses in detail the phytochemistry and pharmacological properties of honey, highlighting the economic and culturally significant medicinal uses of honey and comprehensively reviewing the scientific research on the traditional uses, chemical composition, scientific validation, and general pharmacognostical characteristics. Given its scope, it is a valuable tool for researchers and scientists interested in drug discovery and the chemistry and pharmacology of honey.

This one-of-a-kind medical text covers everything needed to launch a successful career in pharmacy Interprofessional Practice in Pharmacy: Featuring Illustrated Case Studies presents an accessible, in-depth exploration of pharmacists working to advance the safe and effective use of medications. This is an ideal resource for early learners in pharmacy, high school and undergraduate students considering careers in healthcare, and educators and students throughout the health professions. Engaging and robust descriptions demonstrate how pharmacists work within interprofessional teams and contribute to the interprofessional care of patients in multiple healthcare settings. This information will help students identify career opportunities early in their educational journeys. Illustrated case studies-a modern take on a time-tested teaching strategy-provide a unique window into the profession of pharmacy. Readers will enjoy exploring healthcare through the lens of pharmacists, including contemporary issues such as infectious disease outbreaks and the opioid crisis. Over 200 illustrations provide a wide-ranging view of pharmacy practice in the following areas: Community Pharmacy Primary Care Prevention & Wellness Cardiology Pediatrics Geriatrics Infectious Diseases Oncology Emergency Medicine Critical Care Mental Health Technology Population Health Administration

This book highlights recently discovered aspects of "middle-size molecules," focusing on (1) their unique bio-functions on the basis of derivatives and conjugates of natural products, saccharides, peptides, and nucleotides; (2) the synthesis of structurally complex natural products; (3) special synthetic methods for -conjugated functional molecules; and (4) novel synthetic methods using flow chemistry. Given its scope, the book is of interest to industrial researchers and graduate students in the fields of organic chemistry, medicinal chemistry, and materials science.

The biotechnology/biopharmaceutical sector has tremendously grown which led to the invention of engineered antibodies such as Antibody Drug Conjugates (ADCs), Bispecific T-cell engager (BITES), Dual Variable Domain (DVD) antibodies, and fusion proteins that are currently being used as therapeutic agents for immunology, oncology and other disease conditions. Regulatory agencies have raised the bar for the development and manufacture of antibody-based products, expecting to see the use of Quality by Design (QbD) elements demonstrating an in-depth understanding of product and process based on sound science. Drug delivery systems have become an increasingly important part of the therapy and most biopharmaceuticals for self-administration are being marketed as combination products. A survey of the market indicates that there is a strong need for a new book that will provide "one stop shopping" for the latest information and knowledge of the scientific and engineering advances made over the last few years in the area of biopharmaceutical product development. The new book entitled Development of Biopharmaceutical Drug Device Products is a reference text for scientists and engineers in the biopharmaceutical industry, academia or regulatory agencies. With insightful chapters from experts in the field, this new book reviews first principles, covers recent technological advancements and provides case studies and regulatory strategies relating to the development and manufacture of antibody-based products. It covers topics such as the importance of early preformulation studies during drug discovery to influence molecular selection for development, formulation strategies for new modalities, and the analytical techniques used to characterize them. It also addresses important considerations for later stage development such as the development of robust formulations and processes, including process engineering and modeling of manufacturing unit operations, the design of analytical comparability studies, and characterization of primary containers (pre-filled syringes and vials).Finally, the latter half of the book reviews key considerations to ensure the development and approval of a patient-centered delivery system design. This involves the evolving regulatory framework with perspectives from both the US and EU industry experts, the role of international standards, design control/risk management, human factors and its importance in the product development and regulatory approval process, as well as review of the risk-based approach to bridging between devices used in clinical trials and the to-be-marketed device. Finally, case studies are provided throughout.The typical readership would have biology and/or engineering degrees and would include researchers, scientific leaders, industry specialists and technology developers working in the biopharmaceutical field.